David A. Sinclair, A.O., Ph.D., is a renowned expert in the field of aging and longevity, holding a tenured professorship in the Department of Genetics at the Paul F. Glenn Center for Biology of Aging Research at Harvard Medical School. He is acclaimed for pioneering research on the mechanisms of aging and strategies for its mitigation. Dr Sinclair earned his PhD in Molecular Genetics from the University of New South Wales, Sydney, in 1995, and later worked with Dr Leonard Guarente at M.I.T., where he co-discovered critical insights into yeast aging and the epigenetic role of Sir2.
Since joining Harvard Medical School in 1999, Dr Sinclair has dedicated 23 years to advancing the understanding of aging biology and translational medicine for aging. His groundbreaking discoveries include the roles of NAD+ biosynthesis and sirtuins activated by caloric restriction (CR) in lifespan regulation. His development of key theories such as the Xenohormesis Hypothesis and the Information Theory of Aging has shaped the field significantly.
As a thought leader, Dr Sinclair has co-founded several biotechnology companies and serves on various boards, reflecting his influence in health and longevity technology. As co-founder and co-chief editor of the journal Aging, he has shaped scientific dialogue and dissemination in the field. His work is featured in numerous books, films, and high-profile media such as 60 Minutes and Morgan Freeman’s Through the Wormhole.
Dr Sinclair is an inventor with over 50 patents and has been honored with more than 35 prestigious awards, including the CSL Prize, the Nathan Shock Award, and TIME magazine’s recognition as one of the “100 Most Influential People in the World.”
As a keynote speaker and prominent event speaker on topics related to futurism, science, and longevity, Dr Sinclair engages audiences with his insights into the future of healthcare and aging. His extensive list of past and present advisory roles, investments, and licensed inventions enhances his contributions to discussions on the intersection of health and technology. Dr Sinclair remains a sought-after voice for those interested in the cutting-edge developments in longevity and biotechnology, making him an invaluable addition to conferences and symposia around the world.
